Xyla, a national provider of NHS-funded elective care services, is partnering with Ultramed, a pioneering health technology company, to launch a new digital preoperative assessment service using Ultramed’s MyPreOp platform.
Ultramed is a clinical lead health technology company specialising in online pre-procedure assessments. MyPreOp is supported by the NHS Innovation Accelerator for widespread adoption. MyPreOp has already been adopted by 20 NHS Trusts.
It comes at a time when there are over six million patients on waiting lists for elective care and one-third of on-the-day cancellations are related to patients not being clinically ready for treatment.
Recent guidance by NHS England on tackling the COVID-19 backlog of elective care outlines the ambitions for providers to establish perioperative care coordination teams from April 2023 to assist patient health needs, proactively inform pre and post-operative care and identify surgical risk factors.
Earlier pre-operative screening programmes are designed to identify patients with additional health needs who would benefit from extra support both before and after surgery with losing weight, stopping smoking or with their diabetes management.
To support the NHS with this ambition, we’re launching a digital solution for lower-risk patients to enable us to fast-track those who do not need to attend face-to-face pre-operative assessments. By providing the extra capacity to fast-track low-risk patients, more time is available to support patients who require support with smoking cessation and weight loss.
Claire Fisher, Chief Nurse at Xyla, said: “We have seen great patient outcomes from our traditional preoperative assessment services and are excited to really enhance this with our digital solution delivered alongside Ultramed. We expect to see these results grow with further reduced clinical time, enhanced patient satisfaction and streamlined processes for theatre bookings.
“Digital pre-operative assessment is the next stage in the expansion of our digital services which all aim to support the NHS backlog and reduce waiting times whilst creating new capacity for NHS professionals to continue to see those patients who are in greater need of secondary care.”
Alan Sanders, Co-Founder, Ultramed, said: “We are very excited to be partnering alongside Xyla in delivering a premium service.
“Xyla is a trusted, respected brand with a strong customer base and established track record. The adoption of MyPreOp is set to enhance this further – rapidly positioning itself as the leading digital pre-procedure assessment solution.
“Sharing many of the same core values, the synergistic partnership is set to transform respective patient experience and hospital services by opening up access and engagement through complimentary deployment. Ultimately a big step forward in delivering a better, more rounded product to hospitals and patients alike.”
Have any questions about our services? Whether you’re wondering about how we can help your health goals, or assist your healthcare organisation, we’d love to hear from you.
Xyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598), Independent Clinical Services Limited (Registered No 4768329) and CHS Healthcare Software Limited (Registered No 11582111)